Literature DB >> 9930375

Action of angiotensin receptor subtypes on the renal tubules and vasculature: implications for volume homeostasis and atherosclerosis.

C Zitnay1, H M Siragy.   

Abstract

Angiotensin-II (ANG-II) is a potent endocrine and paracrine hormone that functions in humans through two distinct G-protein-coupled transmembrane receptor subtypes (AT-1 and AT-2). ANG-II is found in nearly all tissues of the body including the brain, heart, kidneys, gonads, and gastrointestinal tract. Just as it is found in nearly every organ system of the body, so is it involved in an array of physiologic processes from fetal development to blood pressure control. ANG-II regulates blood pressure by controlling sodium reabsorption in the proximal tubule, altering the glomerular filtration rate and renal blood flow, and by modifying the production and release of aldosterone in the adrenal gland. Additionally, ANG-II is involved in several pathologic processes including the development of hypertension, cardiomyopathy, atherosclerosis, and diabetic nephropathy. It is able to exert influences in these widely varying processes by working together with multiple different second messenger systems including the MAP kinase pathway, nitric oxide production, and phospholipase C and D, and several arachidonic acid metabolites. This paper is a review of the current knowledge of ANG-II and its receptors in health and disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9930375     DOI: 10.1159/000057397

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  4 in total

Review 1.  Prospective trials of angiotensin receptor blockers: beyond blood pressure control.

Authors:  H M Siragy; R M Carey
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

2.  Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population.

Authors:  Ipsita Choudhury; R Jothimalar; Arun Kumar Patra
Journal:  Indian J Clin Biochem       Date:  2012-05-05

Review 3.  The past, present and future of renin-angiotensin aldosterone system inhibition.

Authors:  Robert J Mentz; George L Bakris; Bernard Waeber; John J V McMurray; Mihai Gheorghiade; Luis M Ruilope; Aldo P Maggioni; Karl Swedberg; Ileana L Piña; Mona Fiuzat; Christopher M O'Connor; Faiez Zannad; Bertram Pitt
Journal:  Int J Cardiol       Date:  2012-10-31       Impact factor: 4.164

4.  Neuro-endocrine regulation of blood pressure.

Authors:  Sandeep Chopra; Chris Baby; Jubbin Jagan Jacob
Journal:  Indian J Endocrinol Metab       Date:  2011-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.